The Effect of Attributional Processes Concerning Medication Taking on Return of Fear

Journal of Consulting and Clinical Psychology

Volumn 76, Issue 3, 2008, Pages 478-490

  Powers, Mark B ^a   Smits, Jasper A J ^b   Whitley, Diana ^c   Bystritsky, Alexander ^d   Telch, Michael J ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SOUTHERN METHODIST UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

attributions; claustrophobia; medication; return of fear; safety behaviors

Indexed keywords

CENTRAL STIMULANT AGENT; HERBACEOUS AGENT; PLACEBO; SEDATIVE AGENT;

ADULT; ARTICLE; CLAUSTROPHOBIA; FEAR; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PILL; SELF CONCEPT;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; ASCORBIC ACID; ATTITUDE; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEAR; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PHOBIC DISORDERS; QUESTIONNAIRES; SELF EFFICACY; SEVERITY OF ILLNESS INDEX; WAITING LISTS;

EID: 44949101398     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.76.3.478     Document Type: Article

References (54)

1. Adler D., and Price J.H. Relation of agoraphobics health locus of control orientation to severity of agoraphobia. Psychological Reports 56 (1985) 619-625
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), Author, Washington, DC
3. Anderson C.A., and Arnoult L.H. Attributional style and everyday problems in living: Depression, loneliness, and shyness. Social Cognition 3 (1985) 16-35
4. Bandura A. Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review 84 (1977) 191-215
5. Bandura A. Social foundations of thought and action: A social cognitive (1986), Prentice Hall, Englewood Cliffs, NJ
6. Bandura A., and Adams N.E. Analysis of self-efficacy theory of behavioral change. Cognitive Therapy & Research 1 (1977) 287-310
7. Bandura A., Adams N.E., and Beyer J. Cognitive processes mediating behavioral change. Journal of Personality and Social Psychology 35 (1977) 125-139
8. Bandura A., Reese L., and Adams N.E. Microanalysis of action and fear arousal as a function of differential levels of perceived self-efficacy. Journal of Personality and Social Psychology 43 (1982) 5-21
9. Barlow D.H., Gorman J.M., Shear M.K., and Woods S.W. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Journal of the American Medical Association 283 (2000) 2529-2536
10. Basoglu M., Marks I.M., Kilic C., Brewin C.R., and Swinson R.P. Alprazolam and exposure for panic disorder with agoraphobia: Attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry 164 (1994) 652-659
11. Biondi M., and Picardi A. Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia. Psychotherapy and Psychosomatics 72 (2003) 110-111 author reply, p. 111
12. Borden J.W., Clum G.A., and Salmon P.G. Mechanisms of change in the treatment of panic. Cognitive Therapy and Research 15 (1991) 257-272
13. Bouchard S., Gauthier J., Laberge B., French D., Pelletier M.H., and Godbout C. Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia. Behaviour Research and Therapy 34 (1996) 213-224
14. Bouton M.E. Context, ambiguity, and unlearning: Sources of relapse after behavioral extinction. Biological Psychiatry 52 (2002) 976-986
15. Broadbeck C., and Michelson L. Problem-solving skills and attributional styles of agoraphobics. Cognitive Therapy and Research 11 (1987) 593-610
16. Bruce T.J., Spiegel D.A., and Hegel M.T. Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: A long-term follow-up of the Peoria and Dartmouth studies. Journal of Consulting and Clinical Psychology 67 1 (1999) 151-156
17. Cloitre M., Heimberg R.G., Liebowitz M.R., and Gitow A. Perceptions of control in panic disorder and social phobia. Cognitive Therapy and Research 16 (1992) 569-577
18. Cohen J. Statistical power analysis for the behavioral sciences (1977), Academic Press, New York
19. Devilly G.J., and Borkovec T.D. Psychometric properties of the Credibility/Expectancy Questionnaire. Journal of Behavior Therapy and Experimental Psychiatry 31 (2000) 73-86
20. Emmelkamp P.M., and Cohen-Kettenis P.T. Relationship of locus of control to phobic anxiety and depression. Psychological Reports 36 (1975) 390
21. Foa E.B., Liebowitz M.R., Kozak M.J., Davies S., Campeas R., Franklin M.E., et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 162 (2005) 151-161
22. Furukawa T.A., Watanabe N., and Churchill R. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic review. British Journal of Psychiatry 188 (2006) 305-312
23. Hegel M.T., Lewis Ravaris C., and Ahles T.A. Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder. Behavior Therapy 25 2 (1994) 183-195
24. Hoffart A., and Martinsen E.W. Agoraphobia, depression, mental health locus of control, and attributional styles. Cognitive Therapy and Research 14 (1990) 343-351
25. Jacobson N.S., and Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59 (1991) 12-19
26. Kamphuis J.H., and Telch M.J. Effects of distraction and guided threat reappraisal on fear reduction during exposure-based treatments for specific fears. Behaviour Research and Therapy 38 (2000) 1163-1181
27. Kraemer H.C., Wilson G.T., Fairburn C.G., and Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 59 (2002) 877-883
28. Marks I., Swinson R.P., Basoglu M., Kuch K., Noshirvani H., O'Sullivan G., et al. Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry 162 (1993) 776-787
29. Mystkowski J.L., Mineka S., Vernon L.L., and Zinbarg R.E. Changes in caffeine states enhance return of fear in spider phobia. Journal of Consulting and Clinical Psychology 71 (2003) 243-250
30. Otto M.W., Pollack M.H., Sachs G.S., Reiter S.R., Meltzer-Brody S., and Rosenbaum J.F. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. American Journal of Psychiatry 150 10 (1993) 1485-1490
31. Otto M.W., Smits J.A., and Reese H.E. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analyses. Clinical Psychology: Science & Practice 12 (2005) 72-86
32. Powers M.B., Smits J.A., Leyro T.M., and Otto M.W. Translational research perspectives on maximizing the effectiveness of exposure therapy. In: Richard D.C.S., and Lauterbach D. (Eds). Handbook of the exposure therapies (2007), Academic Press, Burlington, MA 109-126
33. Powers M.B., Smits J.A., and Telch M.J. Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: A placebo-controlled trial. Journal of Consulting and Clinical Psychology 72 (2004) 448-454
34. Radomsky A.S., Rachman S., Thordarson D.S., McIsaac H.K., and Teachman B.A. The Claustrophobia Questionnaire. Journal of Anxiety Disorders 15 (2001) 287-297
35. Rowe M.K., and Craske M.G. Effects of varied-stimulus exposure training on fear reduction and return of fear. Behaviour Research and Therapy 36 (1998) 719-734
36. Roy-Byrne P., Russo J., Dugdale D.C., Lessler D., Cowley D., and Katon W. Undertreatment of panic disorder in primary care: Role of patient and physician characteristics. Journal of the American Board of Family Medicine 15 (2002) 443-450
37. Sloan T., and Telch M.J. The effects of safety-seeking behavior and guided threat reappraisal on fear reduction during exposure: An experimental investigation. Behaviour Research and Therapy 40 (2002) 235-251
38. Smits J.A., Powers M.B., Buxkamper R., and Telch M.J. The efficacy of videotape feedback for enhancing the effects of exposure-based treatment for social anxiety disorder: A controlled investigation. Behaviour Research and Therapy 44 (2006) 1773-1785
39. Spiegel D.A., Bruce T.J., Gregg S.F., and Nuzzarello A. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?. American Journal of Psychiatry 151 6 (1994) 876-881
40. Taylor C., King R., Margraf J., Ehlers A., Telch M., Roth W., et al. Use of medication and in vivo exposure in volunteers for panic disorder research. American Journal of Psychiatry 146 (1989) 1423-1426
41. Telch M.J. Combined pharmacological and psychological treatments for panic sufferers. In: Rachman S., and Maser J. (Eds). Panic: Psychological perspectives (1988), Erlbaum, Hillsdale, NJ 167-187
42. Telch M.J., Tearnan B.H., and Taylor C.B. Antidepressant medication in the treatment of agoraphobia: A critical review. Behavior Research and Therapy 21 (1983) 505-517
43. Telch M.J., Valentiner D.P., Ilai D., Petruzzi D., and Hehmsoth M. The facilitative effects of heart-rate feedback in the emotional processing of claustrophobic fear. Behaviour Research and Therapy 38 (2000) 373-387
44. Telch M.J., Valentiner D.P., Ilai D., Young P.R., Powers M.B., and Smits J.A. Fear activation and distraction during the emotional processing of claustrophobic fear. Journal of Behavior Therapy and Experimental Psychiatry 35 (2004) 219-232
45. Valentiner D.P., Telch M.J., Petruzzi D.C., and Bolte M.C. Cognitive mechanisms in claustrophobia: An examination of Reiss and McNally's expectancy model and Bandura's self-efficacy theory. Cognitive Therapy & Research 20 (1996) 593-612
46. Vansteenwegen D., Vervliet B., Iberico C., Baeyens F., Van den Bergh O., and Hermans D. The repeated confrontation with videotapes of spiders in multiple contexts attenuates renewal of fear in spider-anxious students. Behaviour Research and Therapy 45 (2007) 1169-1179
47. Westra H.A., Stewart S.H., and Conrad B.E. Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia. Journal of Anxiety Disorders 16 (2002) 233-246
48. Williams S.L. Perceived self-efficacy and phobic disability. In: Schwarzer R. (Ed). Self-efficacy: Thought control of action (1992), Hemisphere, Washington, DC 149-176
49. Williams S.L. Self-efficacy and anxiety and phobic disorders. In: Maddux J. (Ed). Self-efficacy, adaptation, and adjustment: Theory, research, and application (1995), Plenum, New York 69-107
50. Williams S.L., Dooseman G., and Kleinfield E. Comparative effectiveness of guided mastery and exposure treatments for intractable phobias. Journal of Consulting and Clinical Psychology 52 (1984) 505-518
51. Williams S.L., Turner S.M., and Peer D.F. Guided mastery and performance desensitization treatments for severe acrophobia. Journal of Consulting and Clinical Psychology 53 (1985) 237-247
52. Williams S.L., and Watson N. Perceived danger and perceived self-efficacy as cognitive mediators of acrophobic behavior. Behavior Therapy 16 (1985) 136-146
53. Wolitzky, K. B., & Telch, M. J. (in press). Augmenting in vivo exposure with fear antagonistic action strategies: Results from a randomized clinical trial. Behavior Therapy
54. World Health Organization. Composite International Diagnostic Interview (CIDI) researcher's manual (1997), American Psychiatric Press, Washington, DC